Risedronate

BreastfeedingPediatric
  • TRADE NAMES: Actonel (Procter & Gamble); Atelvia (Warner Chilcott)
  • INDICATIONS: Paget’s disease of bone, osteoporosis
  • CLASS: Bisphosphonate
  • HALF-LIFE: terminal: 220 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Antacids, Calcium supplements, Iron preparations, Laxatives, Magnesium-based supplements

PREGNANCY CATEGORY: C

Our database has 78 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
MUCOSAL
CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
ENDOCRINE/METABOLIC
GASTROINTESTINAL/HEPATIC
GENITOURINARY
HEMATOLOGIC
NEUROMUSCULAR/SKELETAL
OCULAR
RESPIRATORY
OTHER


Page last updated 09/19/2018

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top